Kalpataru Multiplier Ltd.

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin

BSE2063.900.9 (+0.04 %)

PREV CLOSE () 2063.00

OPEN PRICE () 2075.00

BID PRICE (QTY) 2062.00 (2)

OFFER PRICE (QTY) 2064.85 (13)

VOLUME 11366

TODAY'S LOW / HIGH ()2039.60 2075.00

52 WK LOW / HIGH ()1493.75 2403.45

NSE2061.60-2.8 (-0.14 %)

PREV CLOSE() 2064.40

OPEN PRICE () 2066.20

BID PRICE (QTY) 2060.90 (28)

OFFER PRICE (QTY) 2061.60 (26)

VOLUME 305288

TODAY'S LOW / HIGH() 2035.80 2074.30

52 WK LOW / HIGH ()1493.3 2402.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1983

Management Info :

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 66402323

Email : info@lupin.com

Website : www.lupin.com

Registrar's Details : MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

13May Lupin launches Tolvaptan Tablets in Un
Following the recent approval received from the United States Food and D..

13May Lupin informs about press release
Lupin has informed that it enclosed a Press Release as regards, launch o..

09May Lupin trades higher on getting USFDA’s
Lupin is currently trading at Rs. 2033.50, up by 19.70 points or 0.98% f..

08May Lupin gets USFDA’s nod for Raltegravir
Lupin has received approval from the United States Food and Drug Adminis..

08May Lupin launches Eslicarbazepine Acetate
Lupin has launched Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600..

Financials

in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	9846.7	23260.9
Gross Profit	12170.6	27846.9
Operating Profit	14663.5	35657.9
Net Sales	42080	146665

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Glaxosmithkline Phar (BSE) 2908.00 (4.22%)	M.Cap ( in Cr) 49856.20
Divi's Lab (BSE) 6183.70 (1.86%)	M.Cap ( in Cr) 162649.94
Procter&Gamble Healt (BSE) 5150.00 (1.20%)	M.Cap ( in Cr) 8453.65
Astrazeneca Pharma I (BSE) 8240.00 (0.69%)	M.Cap ( in Cr) 20621.50
Sanofi India (BSE) 5984.50 (0.94%)	M.Cap ( in Cr) 13703.34

Shareholding Pattern

	PROMOTERS	46.92%
	MUTUAL FUNDS/UTI	17.55%
	FI/BANKS/INSURANCE	6.34%
	NON-INSTITUTION	6.2%
	GOVERNMENT	0.01%
	FII	0%

Mf Holding

Scheme Name	Hold(%)
Tata Nifty MidSmall...	8.90
Motilal Oswal Nifty...	8.88
Nippon India Pharma...	7.27
Nippon India Nifty ...	6.52
ICICI Pru Nifty Pha...	6.48
Mirae Asset Healthc...	6.20
ITI Pharma & Health...	5.78